Coronary artery bypass graft surgery-care globalization: The impact of national care on fatal and nonfatal outcome

Journal of Thoracic and Cardiovascular Surgery

Volumn 133, Issue 5, 2007, Pages 1242-1251

  Ott, Elisabeth ^a,b   Mazer, C David ^a,c   Tudor, Iulia C ^a   Shore Lesserson, Linda ^a,d   Snyder Ramos, Stephanie A ^a,e   Finegan, Barry A ^a,f   Möhnle, Patrick ^a,b   Hantler, Charles B ^a,g   Böttiger, Bernd W ^a,e   Latimer, Ray D ^a,h   Browner, Warren S ⁱ   Levin, Jack ^a,j   Mangano, Dennis T ^a  

^a Ischemia Research and Education Foundation   (United States)

^b UNIVERSITY OF MUNICH   (Germany)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d MONTEFIORE MEDICAL CENTER   (United States)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f UNIVERSITY OF ALBERTA   (Canada)

^g WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h PAPWORTH HOSPITAL   (United Kingdom)

ⁱ CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIFIBRINOLYTIC AGENT; APROTININ; HEPARIN;

AGED; ARTICLE; BRAIN ISCHEMIA; CLINICAL PRACTICE; CORONARY ARTERY BYPASS GRAFT; FATALITY; FEMALE; HEALTH CENTER; HEART MUSCLE ISCHEMIA; HUMAN; INTESTINE ISCHEMIA; KIDNEY ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLIC HEALTH SERVICE; THROMBOCYTE;

AGED; CANADA; CORONARY ARTERY BYPASS; FEMALE; GERMANY; GREAT BRITAIN; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 34247346011     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2006.12.031     Document Type: Article

References (40)

1. Mangano D.T. Cardiovascular morbidity and CABG surgery-a perspective: epidemiology, costs, and potential therapeutic solutions. J Card Surg 10 (1995) 366-368
2. van Eck F.M., Noyez L., Verheugt F.W., and Brouwer R.M. Changing profile of patients undergoing redo-coronary artery surgery. Eur J Cardiothorac Surg 21 (2002) 205-211
3. Weintraub W.S., Craver J.M., Jones E.L., Gott J.P., Deaton C., Culler S.D., et al. Improving cost and outcome of coronary surgery. Circulation 98 (1998) I123-I128
4. Unger F. Cardiac interventions in Europe 1997: coronary revascularization procedures and open heart surgery. Cor Europaeum 7 (1999) 177-189
5. Kingma J.H. Waiting for coronary artery bypass surgery: abusive, appropriate, or acceptable?. Lancet 346 (1995) 1570-1571
6. Rosenthal M.B., and Newhouse J.P. Managed care and effective rationing. J Health Care Finance 28 (2002) 1-10
7. Longo K.M., Cowsen M.E., Flaum M.A., Valsania P., Schork M.A., Wagner L.A., et al. Preoperative predictors of cost in Medicare-age patients undergoing coronary artery bypass grafting. Ann Thorac Surg 66 (1998) 740-745
8. Loubani M., Mediratta N., Hickey M.S., and Galinanes M. Early discharge following coronary bypass surgery: is it safe?. Eur J Cardiothorac Surg 18 (2000) 22-26
9. Cheng D.C. Fast-track cardiac surgery: economic implications in postoperative care. J Cardiothorac Vasc Anesth 12 (1998) 72-79
10. Haehnel J.C., Roth P., Lohmann E., Meisner H., and Hehrlein F.W. Implications of the introduction of fixed reimbursement rates in Germany. Thorac Cardiovasc Surg 44 (1996) 97-102
11. Silber S., Muhling H., Dorr R., Zindler G., Preuss A., and Stumpfl A. Waiting times and death on the waiting list for coronary artery bypass operation. Experiences in Munich with over 1,000 patients. Herz 21 (1996) 389-396
12. Bernstein S.J., Rigter H., Brorsson B., Hilborne L.H., Leape L.L., Meijler A.P., et al. Waiting for coronary revascularization: a comparison between New York State, The Netherlands and Sweden. Health Policy 42 (1997) 15-27
13. Shore-Lesserson L. Myocardial injury in cardiac surgery: the role of transfusion. J Cardiothorac Vasc Anesth 4 (2000) 11-14
14. Mangano D.T., and Multicenter Study of Perioperative Ischemia (McSPI) Research Group. Aspirin and mortality from coronary bypass surgery. N Engl J Med 347 (2002) 1309-1317
15. Mangano D.T. Perioperative cardiac morbidity. Anesthesiology 72 (1990) 153-184
16. Roach G.W., Kanchuger M., Mora Mangano C.T., Newman M.F., Nussmeier N.A., Wolman R., et al., Multicenter Study of Perioperative Ischemia (McSPI) Research Group. Adverse cerebral outcomes after coronary bypass surgery. N Engl J Med 335 (1996) 1857-1863
17. Mora Mangano C.T., Diamondstone L.S., Ramsay J.G., Aggarwal A., Herskowitz A., Mangano D.T., and Institutions of the Multicenter Study of Perioperative Ischemia (McSPI) Research Group. Renal dysfunction following myocardial revascularization: risk factors, adverse outcomes and hospital resource utilization. Ann Intern Med 128 (1998) 194-203
18. Fitzgerald T., Kim D., Karakois S., Alam H., Provido H., and Kirkpatrick J. Visceral ischemia after cardiopulmonary bypass. Am Surg 66 (2000) 623-626
19. Nashef S.A., Roques F., Hammill B.G., Peterson E.D., Michel P., Grover F.L., et al. Validation of European System for Cardiac Operative Risk Evaluation (EuroScore) in North American cardiac surgery. Eur J Cardiothorac Surg 22 (2002) 101-105
20. Tinmouth A., Macdougall L., Fergusson D., Amin M., Graham I.D., Hebert P.C., et al. Reducing the amount of blood transfused: a systematic review of behavioral interventions to change physicians' transfusion practices. Arch Intern Med 165 (2005) 845-852
21. Stover E.P., Siegel L.C., Parks R., Levin J., Body S.C., Maddi R., et al., Multicenter Study of Perioperative Ischemia (McSPI) Research Group. Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines: a 24-institution study. Anesthesiology 88 (1998) 327-333
22. Goodnough L.T., Johnston M.F.M., Toy P.T., and Transfusion Medicine Academic Award Group. The variability of transfusion practice in coronary artery bypass surgery. JAMA 265 (1991) 86-90
23. Boldt J., Kling D., von Bormann B., Zuge M., and Hempelmann G. Homologous fresh frozen plasma in heart surgery. Myth or necessity. Anaesthesist 38 (1989) 353-359
24. Boldt J., Knothe C., and Zickman B. Platelet function in cardiac surgery: influence of temperature and aprotinin. Ann Thorac Surg 55 (1993) 652-658
25. Menges T., Rupp D., van Lessen A., and Hempelmann G. Measure for reducing the use of homologous blood. Effects of blood coagulation during total endoprosthesis. Anaesthesist 41 (1992) 27-33
26. Trimble A.S., Osborn J.J., Kerth W.J., and Gerbode F. The prophylactic use of fresh frozen plasma after extracorporeal circulation. J Thorac Cardiovasc Surg 48 (1964) 314-316
27. Kasper G.C., and Welling R.E. Anticoagulation: the rest of the story. Curr Surg 58 (2001) 353-357
28. Wilhelmi M., Franke U., Cohnert T., Weber P., Kaukemuller J., Fischer S., et al. Coronary artery bypass grafting surgery without the routine application of blood products: is it feasible?. Eur J Cardiothorac Surg 19 (2001) 657-661
29. Consten E.C., Henny C.P., Eijsman L., Dongelmans D.A., and van Oers M.H. The routine use of fresh frozen plasma in operations with cardiopulmonary bypass is not justified. J Thorac Cardiovasc Surg 112 (1996) 162-167
30. Spiess B.D. Risks of transfusion: outcome focus. Transfusion 44 (2004) 4S-14S
31. Mangano D.T., Tudor I.C., Dietzel C., and Multicenter Study of Perioperative Ischemia (MCSPI) Research Group and the Ischemia Research and Education Foundation. The risk associated with aprotinin in cardiac surgery. N Engl J Med 354 (2006) 353-365
32. Ad N., Barnett S., Hunt S., Fitzgerald D., and Speir A. The use of aprotinin in cardiac surgery is associated with increased risk of renal failure and neurological events. Circulation 114 (2006) II-476
33. Brown J.R., Birkmeyer N.J.O., and O'Connor G.T. Aprotinin in cardiac surgery. N Engl J Med 354 (2006) 1954-1955
34. Karkouti K., Beattie W.S., Dattilo K.M., McCluskey S.A., Ghannam M., Hamdy A., et al. Blood conservation and transfusion alternatives: a propensity score case-controlled comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery. Transfusion 46 (2006) 327-338
35. Cowper P.A., DeLong E.R., Peterson E.D., Lipscomb J., Muhlbaier L.H., Jollis J.G., et al., IHD Port Investigators. Geographic variation in resource use for coronary artery bypass surgery. Med Care 35 (1997) 320-333
36. Mangano D.T., Miao Y., Vuylsteke A., et al., Multicenter Study of Perioperative Ischemia (McSPI) Research Group and the Ischemia Research and Education Foundation. Mortality associated with aprotinin during 5 years following cardiac artery bypass graft surgery. JAMA 297 (2007) 471-479
37. Nalysnyk L., Fahrbach K., Reynolds M.W., Zhao S.Z., and Ross S. Adverse events in coronary artery bypass graft (CABG) trials: a systematic review and analysis. Heart 89 (2003) 767-772
38. Gregory P.M., Malka E.S., Kostis J.B., Wilson A.C., Arora J.K., and Rhoads G.G. Impact of geographic proximity to cardiac revascularization services on service utilization. Med Care 38 (2000) 45-57
39. Peterson E.D., Coombs L.P., Ferguson T.B., Shrover A.L., DeLong E.R., Grover F.L., et al. Hospital variability in length of stay after coronary artery bypass surgery: results from the Society of Thoracic Surgeon's National Cardiac Database. Ann Thorac Surg 74 (2002) 464-473
40. Sampalis J., Boukas S., Liberman M., Reid T., and Dupuis G. Impact of waiting time on the quality of life of patients awaiting coronary artery bypass grafting. CMAJ 165 (2001) 429-433